Editas Medicine, Inc. (NASDAQ:EDIT) Q2 2024 Earnings Call Transcript August 7, 2024
Editas Medicine, Inc. misses on earnings expectations. Reported EPS is $-0.82137 EPS, expectations were $-0.69.
Operator: Good morning and welcome to the Editas Medicine’s Second Quarter 2024 Conference Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the company’s request. I...
